| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Death and neuroprotection of retinal ganglion cells after different types of injury
|
Vidal-Sanz, Manuel
|
|
2000
|
2 |
2-3 |
p. 215-227
|
article
|
| 2 |
Death and neuroprotection of retinal ganglion cells after different types of injury
|
Vidal-Sanz, Manuel
|
|
|
2 |
2-3 |
p. 215-227
|
article
|
| 3 |
Excitotoxicity of quinolinic acid: Modulation by endogenous antagonists
|
Jhamandas, K. H.
|
|
2000
|
2 |
2-3 |
p. 139-155
|
article
|
| 4 |
Excitotoxicity of quinolinic acid: Modulation by endogenous antagonists
|
Jhamandas, K. H.
|
|
|
2 |
2-3 |
p. 139-155
|
article
|
| 5 |
Neuroprotection in alzheimer’s disease — new strategies for treatment
|
Nordberg, Agneta
|
|
2000
|
2 |
2-3 |
p. 157-165
|
article
|
| 6 |
Neuroprotection in alzheimer’s disease — new strategies for treatment
|
Nordberg, Agneta
|
|
|
2 |
2-3 |
p. 157-165
|
article
|
| 7 |
Neuroprotective and neurorestorative strategies for neuronal injury
|
Beal, M. Flint
|
|
2000
|
2 |
2-3 |
p. 71-84
|
article
|
| 8 |
Neuroprotective and neurorestorative strategies for neuronal injury
|
Beal, M. Flint
|
|
|
2 |
2-3 |
p. 71-84
|
article
|
| 9 |
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
|
Danysz, Wojciech
|
|
2000
|
2 |
2-3 |
p. 85-97
|
article
|
| 10 |
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
|
Danysz, Wojciech
|
|
|
2 |
2-3 |
p. 85-97
|
article
|
| 11 |
Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals
|
Chiueh, Chuang Chin
|
|
2000
|
2 |
2-3 |
p. 293-310
|
article
|
| 12 |
Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals
|
Chiueh, Chuang Chin
|
|
|
2 |
2-3 |
p. 293-310
|
article
|
| 13 |
Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease
|
Yebenes, Justo Garcia de
|
|
2000
|
2 |
2-3 |
p. 115-137
|
article
|
| 14 |
Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease
|
de Yebenes, Justo Garcia
|
|
|
2 |
2-3 |
p. 115-137
|
article
|
| 15 |
Oxidative neuropathology and putative chemical entities for alzheimer’s disease: Neuroprotective effects of salen-manganese catalytic anti-oxidants
|
Rupniak, H. Thomas R.
|
|
2000
|
2 |
2-3 |
p. 167-178
|
article
|
| 16 |
Oxidative neuropathology and putative chemical entities for alzheimer’s disease: Neuroprotective effects of salen-manganese catalytic anti-oxidants
|
Rupniak, H. Thomas R.
|
|
|
2 |
2-3 |
p. 167-178
|
article
|
| 17 |
Prospects for redox-based therapy in neurodegenerative diseases
|
Friedlich, Avi L.
|
|
2000
|
2 |
2-3 |
p. 229-237
|
article
|
| 18 |
Prospects for redox-based therapy in neurodegenerative diseases
|
Friedlich, Avi L.
|
|
|
2 |
2-3 |
p. 229-237
|
article
|
| 19 |
Restoration and putative protection in parkinsonism
|
Archer, Trevor
|
|
2000
|
2 |
2-3 |
p. 251-292
|
article
|
| 20 |
Restoration and putative protection in parkinsonism
|
Archer, Trevor
|
|
|
2 |
2-3 |
p. 251-292
|
article
|
| 21 |
Review on apoptosis vs. necrosis of substantia nigrapars compacta in parkinson’s disease
|
Kostrzewa, Richard M.
|
|
2000
|
2 |
2-3 |
p. 239-250
|
article
|
| 22 |
Review on apoptosis vs. necrosis of substantia nigrapars compacta in parkinson’s disease
|
Kostrzewa, Richard M.
|
|
|
2 |
2-3 |
p. 239-250
|
article
|
| 23 |
Strategies for the protection of dopaminergic neurons against neurotoxicity
|
Gerlach, Manfred
|
|
2000
|
2 |
2-3 |
p. 99-114
|
article
|
| 24 |
Strategies for the protection of dopaminergic neurons against neurotoxicity
|
Gerlach, Manfred
|
|
|
2 |
2-3 |
p. 99-114
|
article
|
| 25 |
The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs
|
Pedersen, Vera
|
|
2000
|
2 |
2-3 |
p. 179-203
|
article
|
| 26 |
The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs
|
Pedersen, Vera
|
|
|
2 |
2-3 |
p. 179-203
|
article
|
| 27 |
The putative neuroprotective role of dopamine agonists in parkinson’s disease
|
Grandas, Francisco
|
|
2000
|
2 |
2-3 |
p. 205-213
|
article
|
| 28 |
The putative neuroprotective role of dopamine agonists in parkinson’s disease
|
Grandas, Francisco
|
|
|
2 |
2-3 |
p. 205-213
|
article
|
Journal description